Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The economic burden of respiratory syncytial virus-associated bronchiolitis hospitalizations.

Literature DB >> 11177073

The economic burden of respiratory syncytial virus-associated bronchiolitis hospitalizations.

P Stang, N Brandenburg, B Carter.

Abstract

Entities: Disease Species

Mesh：

Year: 2001 PMID： 11177073 DOI： 10.1001/archpedi.155.1.95

Source DB: PubMed Journal: Arch Pediatr Adolesc Med ISSN： 1072-4710

Keyword Cloud
Cited

× No keyword cloud information.

26 in total

1. Immunomodulation with IL-4R alpha antisense oligonucleotide prevents respiratory syncytial virus-mediated pulmonary disease.

Authors: Michael J Ripple; Dahui You; Srinivasa Honnegowda; Joseph D Giaimo; Andrew B Sewell; David M Becnel; Stephania A Cormier
Journal: J Immunol Date: 2010-09-22 Impact factor: 5.422

2. A fluorescence polarization assay using an engineered human respiratory syncytial virus F protein as a direct screening platform.

Authors: Minyoung Park; Hisae Matsuura; Robert A Lamb; Annelise E Barron; Theodore S Jardetzky
Journal: Anal Biochem Date: 2010-11-05 Impact factor: 3.365

Review 3. The use of a neonatal mouse model to study respiratory syncytial virus infections.

Authors: Stephania A Cormier; Dahui You; Srinivasa Honnegowda
Journal: Expert Rev Anti Infect Ther Date: 2010-12 Impact factor: 5.091

4. Detection of human respiratory syncytial virus in respiratory samples by LightCycler reverse transcriptase PCR.

Authors: David M Whiley; Melanie W Syrmis; Ian M Mackay; Theo P Sloots
Journal: J Clin Microbiol Date: 2002-12 Impact factor: 5.948

5. Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model.

Authors: Asunción Mejías; Susana Chávez-Bueno; Ana María Ríos; Jesús Saavedra-Lozano; Mónica Fonseca Aten; Jeanine Hatfield; Payal Kapur; Ana María Gómez; Hasan S Jafri; Octavio Ramilo
Journal: Antimicrob Agents Chemother Date: 2004-05 Impact factor: 5.191

The economic burden of respiratory syncytial virus-associated bronchiolitis hospitalizations.

1. Immunomodulation with IL-4R alpha antisense oligonucleotide prevents respiratory syncytial virus-mediated pulmonary disease.

2. A fluorescence polarization assay using an engineered human respiratory syncytial virus F protein as a direct screening platform.

Review 3. The use of a neonatal mouse model to study respiratory syncytial virus infections.

4. Detection of human respiratory syncytial virus in respiratory samples by LightCycler reverse transcriptase PCR.

5. Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model.

6. Kawasaki syndrome hospitalizations and associated costs in the United States.

Review 7. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology.

8. Trends in bronchiolitis hospitalizations in the United States, 2000-2009.

9. Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases.

10. Pharmacological management of acute bronchiolitis.